Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study.
Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study.
复制标题
DOI：
10.1186/s12906-015-0895-x
复制
发表时间：
2015-10-15
影响因子：
--
通讯作者：
Hecht FM
中科院分区：
文献类型：
--
作者：
McDermott K;Kumar D;Goldman V;Feng H;Mehling W;Moskowitz JT;Souza RB;Hecht FM
高血压前期（120-130/80-90 mmHg）患者发展为高血压的风险增加。高血压前期的建议包括定期进行体育锻炼。我们旨在评估ChiRunning对高血压患者的可行性和可接受性，并收集初步结果数据。ChiRunning是一种基于太极正念运动的商业跑步程序，旨在通过提高身体意识和改变跑步形式来减少伤害。我们招募了收缩压（130 - 150mmhg）或舒张压（80 - 100mmhg）升高的成年人，进行了为期12周的先导试验。参与者以2:1:1的比例随机分配至8周：1)干预-教练领导的跑步组（n = 10）；2)主动控制——训练者主导的跑步组（n = 6）；或3)教育控制-自我指导跑步组（n = 6），并随访4周以上。将主动对照组与教育对照组相结合进行分析。这项研究是可行的，符合招募、保留和坚持的目标，并为参与者所接受。在研究过程中，跑步组和对照组的收缩压和舒张压都没有显著变化。随着时间的推移，ChiRunning组的BMI变化与零有显著差异（p = 0.04），而对照组则无显著差异（ChiRunning组的斜率为- 0.05[- 0.1至- 0.002]与对照组的斜率为- 0.01[- 0.06至0.04]，斜率差为p = 0.22）。自述与损伤(即不适导致减少运行)组间相似(ChiRunning 4(1.2 - 8.4)和控制,3[0.7 - 7.1]伤害/ 100 h, p = 0.72)虽然自我报告由跑步引起的不适(如不适,不会导致运行)的变化趋于更高ChiRunning组(ChiRunning 10(5.4 - 16.8)和控制,4 9]报告[1.5每100 h的不适,p = 0.06)。对于血压升高的人来说，跑步似乎是一种可行且可接受的运动项目。我们没有发现跑步对血压或自我报告的伤害有显著影响，但随着时间的推移，我们确实看到了BMI的积极变化。在一个更大的试验中，running值得进一步调查。ClinicalTrials.gov标识符：NCT01587183
People with prehypertension (120–130/80–90 mmHg) are at increased risk of progressing to hypertension. Recommendations for prehypertension include engaging in regular physical activity. We aimed to assess feasibility and acceptability and collect preliminary outcome data on ChiRunning for people with elevated blood pressure. ChiRunning is a commercially available running program based on the mindful movements of Tai Chi, which is aimed at decreasing injury by both increasing body awareness and modifying running form. We enrolled adults with elevated systolic (130–150 mmHg) or diastolic (80–100 mmHg) blood pressure in a 12-week pilot trial. Participants were randomized 2:1:1 to 8 weeks of: 1) intervention—a trainer-led ChiRunning group (n = 10); 2) active control—a trainer-led running group (n = 6); or 3) educational control—a self-directed running group (n = 6) and followed for 4 more weeks. The active control and educational control groups were combined for analysis. This study was feasible, meeting recruitment, retention and adherence goals, and acceptable to participants. Systolic and diastolic blood pressure did not change significantly over the study for either the ChiRunning or control groups. Changes in BMI over time were significantly different from zero in the ChiRunning group (p = 0.04) but not in the control group (slope for ChiRunning −0.05 [−0.1 to −0.002] vs. control −0.01 [−0.06 to 0.04], between slope difference, p = 0.22). Self-reported running-related injury (i.e. discomfort leading to a decrease in running) was similar between groups (ChiRunning, 4 [1.2 to 8.4] vs. control, 3 [0.7 to 7.1] injuries per 100 h of running, p = 0.72) although self-reported running-related discomfort (i.e. discomfort that does not lead to changes in running) trended higher in the ChiRunning group (ChiRunning, 10 [5.4 to 16.8] vs. control, 4 [1.5 to 9] reports of discomfort per 100 h of running, p = 0.06). ChiRunning appears to be a feasible and acceptable exercise program for people with elevated blood pressure. We did not find that ChiRunning had a significant impact on blood pressure or self reported injury, but did see a positive change in BMI over time. ChiRunning warrants further investigation in a larger trial. ClinicalTrials.gov Identifier: NCT01587183